Literature DB >> 14559408

Techniques: magnetic resonance imaging of the lung provides potential for non-invasive preclinical evaluation of drugs.

Nicolau Beckmann1, Bruno Tigani, Lazzaro Mazzoni, John R Fozard.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14559408     DOI: 10.1016/j.tips.2003.08.009

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  5 in total

1.  Brain T1 intensity changes after levodopa administration in healthy subjects: a voxel-based morphometry study.

Authors:  Pilar Salgado-Pineda; Pauline Delaveau; Carles Falcon; Olivier Blin
Journal:  Br J Clin Pharmacol       Date:  2006-06-23       Impact factor: 4.335

2.  Evaluation of lung inflammation induced by intratracheal administration of LPS in mice: comparison between MRI and histology.

Authors:  Giamaica Conti; Stefano Tambalo; Gino Villetti; Silvia Catinella; Chiara Carnini; Franco Bassani; Nicolò Sonato; Andrea Sbarbati; Pasquina Marzola
Journal:  MAGMA       Date:  2010-04-13       Impact factor: 2.310

3.  Longitudinal, in vivo assessment of invasive pulmonary aspergillosis in mice by computed tomography and magnetic resonance imaging.

Authors:  Jennifer Poelmans; Amy Hillen; Liesbeth Vanherp; Kristof Govaerts; Johan Maertens; Tom Dresselaers; Uwe Himmelreich; Katrien Lagrou; Greetje Vande Velde
Journal:  Lab Invest       Date:  2016-03-28       Impact factor: 5.662

4.  Imaging techniques for small animal models of pulmonary disease: MR microscopy.

Authors:  Bastiaan Driehuys; Laurence W Hedlund
Journal:  Toxicol Pathol       Date:  2007-01       Impact factor: 1.902

5.  In vivo pharmacological evaluation of compound 48/80-induced airways oedema by MRI.

Authors:  H Karmouty-Quintana; F-X Blé; C Cannet; S Zurbruegg; J R Fozard; C P Page; N Beckmann
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.